Cargando…

IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA

BACKGROUND: Pediatric brain tumors (PBTs) are the leading cause of cancer-related death in children. Currently, based on the RAPNO guidelines, two-dimensional (2D) measurements are used to detect progression. However, due to the complex radiographic appearance of many PBTs, 2D measurements may not a...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalili, Nastaran, Kazerooni, Anahita Fathi, Bagheri, Sina, Familiar, Ariana, Viswanathan, Karthik, Anderson, Hannah, Haldar, Debanjan, Ware, Jeffrey B, Vossough, Arastoo, Nabavizadeh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260107/
http://dx.doi.org/10.1093/neuonc/noad073.185
_version_ 1785057790345084928
author Khalili, Nastaran
Kazerooni, Anahita Fathi
Bagheri, Sina
Familiar, Ariana
Viswanathan, Karthik
Anderson, Hannah
Haldar, Debanjan
Ware, Jeffrey B
Vossough, Arastoo
Nabavizadeh, Ali
author_facet Khalili, Nastaran
Kazerooni, Anahita Fathi
Bagheri, Sina
Familiar, Ariana
Viswanathan, Karthik
Anderson, Hannah
Haldar, Debanjan
Ware, Jeffrey B
Vossough, Arastoo
Nabavizadeh, Ali
author_sort Khalili, Nastaran
collection PubMed
description BACKGROUND: Pediatric brain tumors (PBTs) are the leading cause of cancer-related death in children. Currently, based on the RAPNO guidelines, two-dimensional (2D) measurements are used to detect progression. However, due to the complex radiographic appearance of many PBTs, 2D measurements may not accurately reflect tumor growth. Here, we compared 3D, 2D, and qualitative radiologists’ interpretations in a group of PBTs to determine tumor progression. METHODS: Six PBT patients (5 low-grade glioma, 1 ependymoma, age range at the time of baseline scan: 23-191 months) with an average of 5 imaging time points who had at least one episode of progression with subsequent surgery were included. Segmentation was performed on either T1 post-contrast or FLAIR, whichever that best identified the tumor. For 2D measurements, the two largest perpendicular diameters in a section that included the largest tumor component were measured. For the volumetric assessment, the tumors were manually segmented, and the volume was computed using the ITK-SNAP software. In multifocal tumors, only the tumor component that showed progression and underwent resection was included. A 25% and 41% increase in tumor size was considered as progression on 2D and 3D measurements, respectively. The time to progression (TTP) based on 2D vs 3D assessment as well as the official pediatric neuroradiologist interpretation based on the electronic health record report was compared. RESULTS: In three of six patients, volumetric segmentation detected tumor progression at an earlier time point compared to 2D measurements and radiologists’ interpretation (median TTP: 134 compared to 503 for 2D and radiologist interpretation). For these three patients, the TTP based on 3D vs 2D assessment was: 252 vs 1299 days, 134 vs 503 days, and 80 vs 255 days. CONCLUSION: Volumetric measurements can determine tumor progression earlier than the current standard method of 2D measurements and qualitative interpretation of radiologists in PBTs.
format Online
Article
Text
id pubmed-10260107
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102601072023-06-13 IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA Khalili, Nastaran Kazerooni, Anahita Fathi Bagheri, Sina Familiar, Ariana Viswanathan, Karthik Anderson, Hannah Haldar, Debanjan Ware, Jeffrey B Vossough, Arastoo Nabavizadeh, Ali Neuro Oncol Final Category: Imaging - IMG BACKGROUND: Pediatric brain tumors (PBTs) are the leading cause of cancer-related death in children. Currently, based on the RAPNO guidelines, two-dimensional (2D) measurements are used to detect progression. However, due to the complex radiographic appearance of many PBTs, 2D measurements may not accurately reflect tumor growth. Here, we compared 3D, 2D, and qualitative radiologists’ interpretations in a group of PBTs to determine tumor progression. METHODS: Six PBT patients (5 low-grade glioma, 1 ependymoma, age range at the time of baseline scan: 23-191 months) with an average of 5 imaging time points who had at least one episode of progression with subsequent surgery were included. Segmentation was performed on either T1 post-contrast or FLAIR, whichever that best identified the tumor. For 2D measurements, the two largest perpendicular diameters in a section that included the largest tumor component were measured. For the volumetric assessment, the tumors were manually segmented, and the volume was computed using the ITK-SNAP software. In multifocal tumors, only the tumor component that showed progression and underwent resection was included. A 25% and 41% increase in tumor size was considered as progression on 2D and 3D measurements, respectively. The time to progression (TTP) based on 2D vs 3D assessment as well as the official pediatric neuroradiologist interpretation based on the electronic health record report was compared. RESULTS: In three of six patients, volumetric segmentation detected tumor progression at an earlier time point compared to 2D measurements and radiologists’ interpretation (median TTP: 134 compared to 503 for 2D and radiologist interpretation). For these three patients, the TTP based on 3D vs 2D assessment was: 252 vs 1299 days, 134 vs 503 days, and 80 vs 255 days. CONCLUSION: Volumetric measurements can determine tumor progression earlier than the current standard method of 2D measurements and qualitative interpretation of radiologists in PBTs. Oxford University Press 2023-06-12 /pmc/articles/PMC10260107/ http://dx.doi.org/10.1093/neuonc/noad073.185 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Final Category: Imaging - IMG
Khalili, Nastaran
Kazerooni, Anahita Fathi
Bagheri, Sina
Familiar, Ariana
Viswanathan, Karthik
Anderson, Hannah
Haldar, Debanjan
Ware, Jeffrey B
Vossough, Arastoo
Nabavizadeh, Ali
IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title_full IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title_fullStr IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title_full_unstemmed IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title_short IMG-08. VOLUMETRIC MEASUREMENT OF TUMOR SIZE OUTPERFORMS STANDARD TWO-DIMENSIONAL METHOD IN EARLY PREDICTION OF TUMOR PROGRESSION IN PEDIATRIC GLIOMA
title_sort img-08. volumetric measurement of tumor size outperforms standard two-dimensional method in early prediction of tumor progression in pediatric glioma
topic Final Category: Imaging - IMG
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260107/
http://dx.doi.org/10.1093/neuonc/noad073.185
work_keys_str_mv AT khalilinastaran img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT kazeroonianahitafathi img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT bagherisina img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT familiarariana img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT viswanathankarthik img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT andersonhannah img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT haldardebanjan img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT warejeffreyb img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT vossougharastoo img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma
AT nabavizadehali img08volumetricmeasurementoftumorsizeoutperformsstandardtwodimensionalmethodinearlypredictionoftumorprogressioninpediatricglioma